Renova Privat International Oncology Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 02-12-2024
- Paid Up Capital ₹ 0.20 K
as on 02-12-2024
- Company Age 8 Months 5 Days
About Renova Privat International Oncology
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.20 K , as per Ministry of Corporate Affairs (MCA) records.
Kalyan Sachdev and Abhijeet Sachdev serve as directors at the Company.
- CIN/LLPIN
U86100DL2024PTC429901
- Company No.
429901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Renova Privat International Oncology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeet Sachdev  | Director | 16-Apr-2024 | Current |
| Kalyan Sachdev | Director | 16-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Renova Privat International Oncology.
Enhance accessibility to Renova Privat International Oncology's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Renova Privat International Oncology?
Unlock access to Renova Privat International Oncology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prime Air Ambulance Private LimitedActive 15 years 5 monthsKalyan Sachdev and Abhijeet Sachdev are mutual person
Asia Medical Assistance Private LimitedActive 21 years 4 monthsKalyan Sachdev and Abhijeet Sachdev are mutual person
Medinyx Software Solutions Private LimitedActive 12 years 7 monthsKalyan Sachdev and Abhijeet Sachdev are mutual person
Privat Hospitals Dr Sachdev Private Ltd.Active 38 years 6 monthsKalyan Sachdev and Abhijeet Sachdev are mutual person
Privat Healthcare Ventures Private LimitedActive 16 years 10 monthsKalyan Sachdev and Abhijeet Sachdev are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Renova Privat International Oncology?
Renova Privat International Oncology has a workforce of 0 employees as of May 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renova Privat International Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renova Privat International Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.